Alzheimer’s trial results lend momentum to drugs targeting tau
J
Jennie Erin Smith
Abstract
First drug to lower the protein and slow cognitive decline created buzz despite puzzling data
Article Details
Journal
Science
Volume / Issue
Vol. 393, Issue 6809
Published
July 23, 2026
Pages
343-344
ISSN
0036-8075
Publisher
American Association for the Advancement of Science
Journal Info
Science
American Association for the Advancement of Science
ISSN: 0036-8075 Social Sciences
Authors (1)
J
Jennie Erin Smith
Related Articles from this Journal
Constraining an exoplanet’s magnetic field using star-planet interactions
D. Revilla, P. J. Amado et al.
Jul 2026
10.1126/science.adv3075
Epigenetic and 3D genome reprogramming during the aging of the human hippocampus
Nathan R. Zemke, Seoyeon Lee et al.
Jul 2026
10.1126/science.adt8307
Step geometry–guided growth of rhombohedral graphene
Mengze Zhao, Zhibin Zhang et al.
Jul 2026
10.1126/science.aed9202
Brazil’s environmental governance at risk
Marcus V. Cianciaruso, Luis Mauricio Bini et al.
Jul 2026
10.1126/science.aej1473
Genome in motion: Mapping the nucleus in health
Di Jiang, Yevgeniya Nusinovich et al.
Jul 2026
10.1126/science.aek3868